We could live in a future world where people pick and choose the traits their babies have, but it may not be the right thing to do.
It’s just one of the many ethical dilemmas that Francis deSouza, CEO of genomics testing company Illumina, who was interviewed by CNBC’s Christina Farr Wednesday at the Code Conference in Rancho Palos Verdes, Calif. llumina sells DNA sequencing technology to companies such as 23andMe and Ancestry.com.
“There was a wealthy industrialist mogul from Silicon Valley who was curious about designer babies for him and his partner,” said deSouza. “With that much power, there are lots of questions that we will have to address about what it means to be human.”